» Authors » Mehdi Allahbakhshian Farsani

Mehdi Allahbakhshian Farsani

Explore the profile of Mehdi Allahbakhshian Farsani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hajipirloo L, Nabigol M, Khayami R, Karami N, Farsani M, Navidinia A
Curr Res Transl Med . 2025 Jan; 73(2):103492. PMID: 39818173
Background: Stromal cells play a pivotal role in the tumor microenvironment (TME), significantly impacting the progression of acute myeloid leukemia (AML). This study sought to develop a stromal-related prognostic model...
2.
Kuhestani-Dehaghi B, Amirpour M, Nabigol M, Keshavarz A, Vazifeh Shiran N, Rahmani-Seraji H, et al.
Mol Biol Rep . 2024 Dec; 52(1):62. PMID: 39692942
Background: The progression of leukemia is substantially associated with the interactions of leukemic cells with surrounding cells within the bone marrow microenvironment (BMM), and these interactions were facilitated using exosomes...
3.
Nabigol M, Hajipirloo L, Kuhestani-Dehaghi B, Farsani M
Curr Res Transl Med . 2024 Oct; 73(1):103474. PMID: 39366080
Purpose Of Study: Despite the various therapeutic options introduced for AML treatment, therapy resistance and relapse are still the main obstacles. It is well known that alterations in the bone...
4.
Keshavarz A, Navidinia A, Kuhestani Dehaghi B, Amiri V, Mohammadi M, Farsani M
Mol Biotechnol . 2024 May; PMID: 38714601
Acute myeloid leukemia (AML) is a lethal hematologic malignancy with a variable prognosis that is highly dependent on the bone marrow microenvironment. Consequently, a better understanding of the AML microenvironment...
5.
Gorji M, Farsani M, Kargar M, Garavand J, Mohammadi M
Curr Res Transl Med . 2024 Jan; 72(2):103429. PMID: 38246071
Background: Acute myeloid leukemia (AML) has been the most prevalent form of acute leukemia among adults, and it has been associated with poor survival rates over the last four decades....
6.
Mizani S, Keshavarz A, Vazifeh Shiran N, Bashash D, Farsani M
Indian J Hematol Blood Transfus . 2023 Jun; 39(3):392-401. PMID: 37304466
The increased metabolism in acute myeloid leukemia (AML) malignant cells resulted in the production of high levels of free radicals, called oxidative stress conditions. To avoid this situation, malignant cells...
7.
Zaka Khosravi S, Ramshe S, Farsani M, Moonesi M, Marofi F, Farshdousti Hagh M
J Recept Signal Transduct Res . 2023 May; 43(2):50-61. PMID: 37186553
The angiogenesis efficacy in solid tumors and hematological malignancies has been identified for more than twenty years. Although the exact role of angiogenesis in leukemia as a common hematological malignancy...
8.
Rassaei N, Abbaszade Dibavar M, Soleimani M, Atashi A, Mohammadi M, Farsani M, et al.
Iran J Basic Med Sci . 2023 Mar; 26(3):295-300. PMID: 36865039
Objectives: Microvesicles (MVs) are small membrane-bound particles that act as a vehicle to transfer their contents, such as proteins, RNAs, and miRNAs, to the target cells, making them undergo several...
9.
Kargar-Sichani Y, Mohammadi M, Amiri V, Barzegar M, Keshavarz A, Bashash D, et al.
Arch Med Res . 2023 Jan; 54(2):95-104. PMID: 36717322
Objective: Acute myeloid leukemia (AML) is a heterogeneous clonal disorder resulting from a complex interplay between leukemic cells and supporting factors from their microenvironment. In this context, extracellular vesicles (EVs)...
10.
Amiri V, Mohammadi M, Rafiee M, Ghezelbash B, Salari S, Farsani M
Curr Res Transl Med . 2021 Aug; 69(4):103311. PMID: 34455155
Epigenetic alterations could cause leukemia through the activation of normally silent loci or silencing of normally active loci. We herein aimed to compare the expression patterns of a histone modifiers...